Pfizer stock jumps, Moderna, Merck tumble
November 05, 2021 at 13:28 PM EDT
Pfizer's stock soars after it delivers groundbreaking results for its COVID-19 oral antiviral candidate, PAXLOVID.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|